Published in Proc Natl Acad Sci U S A on February 13, 2012
A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest (2015) 1.29
Novel strategies for the prevention and treatment of biofilm related infections. Int J Mol Sci (2013) 1.11
Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner. PLoS Pathog (2014) 0.95
New paradigms in sepsis: from prevention to protection of failing microcirculation. J Thromb Haemost (2015) 0.89
Adhesin competence repressor (AdcR) from Streptococcus pyogenes controls adaptive responses to zinc limitation and contributes to virulence. Nucleic Acids Res (2014) 0.88
A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J Biol Chem (2012) 0.87
An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus. MBio (2015) 0.87
Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation. PLoS One (2012) 0.86
Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression. Bioorg Med Chem (2013) 0.82
A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. PLoS Pathog (2013) 0.80
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cell Infect Microbiol (2014) 0.80
Chemical biology applied to the study of bacterial pathogens. Infect Immun (2014) 0.79
Sharpening Host Defenses during Infection: Proteases Cut to the Chase. Mol Cell Proteomics (2017) 0.78
The role of HTS in drug discovery at the University of Michigan. Comb Chem High Throughput Screen (2014) 0.78
Heterologous expression of Ralp3 in Streptococcus pyogenes M2 and M6 strains affects the virulence characteristics. PLoS One (2013) 0.78
Emergence of antibiotic-resistant extremophiles (AREs). Extremophiles (2012) 0.78
Pathogen activators of plasminogen. J Thromb Haemost (2015) 0.76
Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth. Antimicrob Agents Chemother (2015) 0.76
Constitutive optimized production of streptokinase in Saccharomyces cerevisiae utilizing glyceraldehyde 3-phosphate dehydrogenase promoter of Pichia pastoris. Biomed Res Int (2013) 0.75
Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents. Bioorg Med Chem Lett (2014) 0.75
Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection. Sci Rep (2017) 0.75
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol (2006) 5.22
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol (1991) 4.99
Streptococcal infections of skin and soft tissues. N Engl J Med (1996) 4.78
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med (2007) 4.35
Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov (2010) 4.23
Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science (2005) 3.26
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science (2004) 2.91
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today (2003) 2.78
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis (2001) 2.51
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2008) 2.02
The pathogenic equine streptococci. Vet Res (2004) 1.91
Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog (2009) 1.87
Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog (2008) 1.83
Independent evolution of competence regulatory cascades in streptococci? Trends Microbiol (2006) 1.66
Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol (2008) 1.62
Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One (2008) 1.49
Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun (2006) 1.42
A genome-wide analysis of small regulatory RNAs in the human pathogen group A Streptococcus. PLoS One (2009) 1.36
The molecular basis of Streptococcus equi infection and disease. Microbes Infect (2002) 1.32
Identification and structural basis of binding to host lung glycogen by streptococcal virulence factors. Nat Struct Mol Biol (2006) 1.28
A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol (2000) 1.28
Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27
Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Infect Immun (2006) 1.22
Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect Immun (2004) 1.20
Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect Immun (2009) 1.20
Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation. J Infect Dis (1991) 1.14
Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms. J Infect Dis (2003) 1.12
Streptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase. Infect Immun (2003) 1.12
The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol Sci (2010) 1.12
The present state of species within the genera Streptococcus and Enterococcus. Int J Med Microbiol (2007) 1.09
Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. Antimicrob Agents Chemother (2004) 1.06
Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase. J Biol Chem (2004) 1.00
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother (2006) 1.00
Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase. J Biol Chem (2004) 0.97
Species specificity of streptokinase. Comp Biochem Physiol B (1983) 0.95
Regulation of polysaccharide utilization contributes to the persistence of group a streptococcus in the oropharynx. Infect Immun (2007) 0.91
Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma. Infect Immun (1999) 0.89
Characterization of a novel streptokinase produced by Streptococcus equisimilis of non-human origin. Thromb Haemost (1994) 0.87
Control of streptokinase gene expression in group A & C streptococci by two-component regulators. Indian J Med Res (2004) 0.82
Streptococcal inhibitor of complement-mediated lysis (SIC): an anti-inflammatory virulence determinant. Microbiology (2010) 0.79
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol (2006) 6.24
Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res (2005) 5.71
High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods (2011) 5.68
Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol (2005) 5.18
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A (2002) 4.85
spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol (2004) 4.80
Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A (2008) 4.38
Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89
Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A (2002) 3.83
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog (2006) 3.68
Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2006) 3.33
Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis (2005) 3.32
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nat Med (2013) 3.15
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science (2004) 2.91
Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A (2005) 2.84
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med (2012) 2.62
Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A (2014) 2.56
Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A (2003) 2.54
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest (2005) 2.50
Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A (2005) 2.45
Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis (2005) 2.45
Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43
Molecular correlates of host specialization in Staphylococcus aureus. PLoS One (2007) 2.41
Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A (2004) 2.32
Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis (2004) 2.29
The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol (2002) 2.27
Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One (2007) 2.22
Systemic antithrombotic effects of ADAMTS13. J Exp Med (2006) 2.21
In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J Bacteriol (2002) 2.19
Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect Immun (2002) 2.10
Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05
A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2008) 2.02
Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol (2007) 2.01
Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (2003) 1.99
Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J (2005) 1.98
Characterization of the Manila family of Mycobacterium tuberculosis. J Clin Microbiol (2003) 1.89
Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One (2007) 1.89
Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch Pathol Lab Med (2011) 1.83
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet (2003) 1.82
Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J Biol Chem (2003) 1.81
Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes. Infect Immun (2002) 1.79
Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun (2002) 1.78
Trigger for group A streptococcal M1T1 invasive disease. FASEB J (2006) 1.77
Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A (2011) 1.70
rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol (2006) 1.68
Identification and characterization of HtsA, a second heme-binding protein made by Streptococcus pyogenes. Infect Immun (2003) 1.68
Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J Infect Dis (2003) 1.68
An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol (2003) 1.66
Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect Immun (2003) 1.66
Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun (2010) 1.62
CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun (2009) 1.62
Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol (2008) 1.62
Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther (2014) 1.61
Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation (2005) 1.61
Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol (2003) 1.59
Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice. Blood (2009) 1.58
Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect Immun (2003) 1.57
ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Blood (2003) 1.57
Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol (2010) 1.56
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A (2002) 1.55
The agr radiation: an early event in the evolution of staphylococci. J Bacteriol (2005) 1.55
Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. Hepatology (2014) 1.55
A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun (2008) 1.54
Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol (2006) 1.53
Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect Immun (2003) 1.53
Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun (2003) 1.53
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51
Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol (2003) 1.50
Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One (2008) 1.49
Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis (2003) 1.49
Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A (2010) 1.47
LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem (2005) 1.44
Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun (2006) 1.42
Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci U S A (2002) 1.42
New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol (2007) 1.41
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet (2009) 1.40
Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J Infect Dis (2003) 1.39
Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A (2011) 1.39
The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol (2008) 1.38
Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun (2005) 1.37
Evidence for recombination in Mycobacterium tuberculosis. J Bacteriol (2006) 1.37
Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype. Infect Immun (2014) 1.36
Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics (2004) 1.35
Negative Regulation of AKT Activation by BRCA1. Cancer Res (2008) 1.34
Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob Agents Chemother (2003) 1.33
Genome sequence survey identifies unique sequences and key virulence genes with unusual rates of amino Acid substitution in bovine Staphylococcus aureus. Infect Immun (2002) 1.33
Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A (2005) 1.33
Tuberculosis disparity between US-born blacks and whites, Houston, Texas, USA. Emerg Infect Dis (2009) 1.33
Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences. J Clin Microbiol (2010) 1.32